<DOC>
	<DOC>NCT01457716</DOC>
	<brief_summary>The aim of the study is to assess and compare the Pharmacokinetic (PK) of Budesonide and Formoterol after administration of 3 different product variants of Budesonide/Formoterol Easyhalers and Symbicort turbuhaler.</brief_summary>
	<brief_title>Pharmacokinetic Pilot Study on Budesonide/Formoterol</brief_title>
	<detailed_description />
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Healthy males and females, 1855 years of age. Normal weight at least 50 kg. Evidence of a clinically significant cardiovascular, renal, hepatic, haematological, gastrointestinal, pulmonary, metabolicendocrine, neurological or psychiatric disease. Any condition requiring concomitant treatment (including vitamins and herbal products)or likely to need any concomitant treatment during the study Any clinically significant abnormal laboratory value or physical finding that may interfere with the interpretation of test results or cause a health risk for the subject if he/she participates in the study. Known hypersensitivity to the active substance(s) or to any of the excipients of the drug. Pregnant or lactating females.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Healthy volunteer study</keyword>
</DOC>